iShares Health Innovation Active ETF · $14M$12,713
BMEDBMED vsIBBIBBiShares Biotechnology ETF · $11.2B$14,214
$10,000 five years ago, dividends reinvested · they hold 34.9% in common
BMEDMeasureIBB
Returns · dividends reinvested
+23.3%Year to dateJan 1 → Nov 4+31.1%
+32.3%1 yearTotal return+40.7%
+21.9%3 years · per year$10,000 became $18,098 · $19,707+25.4%
+4.9%5 years · per year$10,000 became $12,713 · $14,214+7.3%
Cost and income
0.77%Expense ratio$77 · $44 a year on $10k · lower is better0.44%
0.22%Trailing 12-mo yield$22 · $15 a year on $10k0.15%
Risk · past year
−14.9%Worst dropSmaller is better−9.6%
17.9%VolatilityLower is calmer22.8%
BMEDIBB Winner of the row, in its colourEach row: the bigger of the two fills its side
2–6IBB wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns